Change to UK Patents Act Removes Infringement For Use Of Clinical Trial Data
The United Kingdom government has announced a change to the UK Patents Act that it says will help keep the country’s life sciences industry at the forefront of innovation by removing certain risks of drug development companies infringing patents.
